6568 — KNC Laboratories Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedMicro CapSuper Stock

Annual balance sheet for KNC Laboratories Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1,974	2,297	3,312	2,386	2,173
Net Total Accounts Receivable
Net Total Receivables	2,518	2,791	2,626	2,408	1,735
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,347	7,459	8,559	7,475	7,811
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,909	7,200	8,475	11,147	12,277
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	13,952	15,405	18,622	20,152	21,644
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,047	2,728	2,969	2,269	2,726
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	3,377	3,659	5,535	6,632	7,564
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	10,575	11,745	13,087	13,520	14,081
Total Liabilities & Shareholders' Equity	13,952	15,405	18,622	20,152	21,644
Total Common Shares Outstanding